Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Goals
Fat LossMuscle BuildingInjury HealingAnti-AgingCognitive EnhancementSleep OptimizationImmune SupportGut HealingSkin RejuvenationSexual Health
Peptides
Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PNC-27
Cancer Research
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 32
Back to Home

Peptide Comparison

Apelin-13vsBPC-157

A natural heart hormone that helps your cardiovascular system work better and supports healthy blood flow throughout your body.

The "Wolverine peptide" known for its remarkable healing properties across tendons, ligaments, muscles, and the gut.

Healing & RecoveryHealing & Recovery

At a Glance

Quick
comparison

Dose Range

Apelin-13

As prescribed–As prescribed mg

BPC-157

250–500 mcg

Frequency

Apelin-13

Once daily

BPC-157

Once daily

Administration

Apelin-13

Intravenous (IV)

BPC-157

Subcutaneous injection

Cycle Length

Apelin-13

Ongoing/indefinite

BPC-157

4-6 weeks

Onset Speed

Apelin-13

Moderate (1-2 weeks)

BPC-157

Moderate (1-2 weeks)

Evidence Level

Apelin-13

Moderate human trials (Phase 1-2)

BPC-157

Strong preclinical (extensive animal studies)

Efficacy

Benefit
ratings

Apelin-13
BPC-157

Cardiovascular Support

Apelin-1382%
BPC-1570%

Heart Function & Strength

Apelin-1378%
BPC-1570%

Blood Flow & Circulation

Apelin-1374%
BPC-1570%

Primary Benefit

Apelin-130%
BPC-15785%

Secondary Benefit

Apelin-130%
BPC-15778%

Additional Benefit

Apelin-130%
BPC-15772%

Technical Data

Compound
specifications

Apelin-13

Molecular Formula

C69H111N23O16S

Molecular Weight

1550.8 Da

Half-Life

Minutes in plasma; varies by route of administration

Bioavailability

~90-95% (subcutaneous injection)

CAS Number

Not yet assigned (research compound)

BPC-157

Molecular Formula

C62H98N16O22

Molecular Weight

1419.53 g/mol

Half-Life

4-6 hours

Bioavailability

~100% (subcutaneous)

CAS Number

137525-51-0

Protocols

Dosing
tiers

Apelin-13

BPC-157

starting

250 mcg

Once daily

1-2 weeks

Start here to assess tolerance. Can split into AM/PM if preferred.

standard

250-500 mcg

Twice daily

4-6 weeks

Most common protocol. Split doses morning and evening for best results.

advanced

500 mcg

Twice daily

6-8 weeks

For experienced users or severe injuries. Higher doses not shown to improve outcomes significantly.

Applications

Best
suited for

Apelin-13

Research into cardiovascular health and heart function

Apelin-13 is particularly well-suited for individuals focused on research into cardiovascular health and heart function. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Understanding how the body naturally protects the heart

Apelin-13 is particularly well-suited for individuals focused on understanding how the body naturally protects the heart. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Exploring potential treatments for heart failure

Apelin-13 is particularly well-suited for individuals focused on exploring potential treatments for heart failure. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Studying mechanisms of heart muscle strength

Apelin-13 is particularly well-suited for individuals focused on studying mechanisms of heart muscle strength. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

BPC-157

Tendon and ligament injuries

Sprains, strains, tears, tendinitis - BPC-157 accelerates collagen synthesis and tissue repair

Gut healing

IBS, leaky gut, ulcers, inflammatory bowel conditions - derived from gastric juice, it has a natural affinity for digestive tissue

Muscle injuries

Strains, post-workout recovery, chronic muscle issues - promotes angiogenesis and growth factor expression

Joint problems

Arthritis support, joint pain, cartilage issues - anti-inflammatory and regenerative properties

Post-surgical recovery

Accelerating healing after procedures - works systemically to enhance the body's repair mechanisms

Safety Profile

Side
effects

Apelin-13

Common

  • Mild changes in blood pressure
  • Minimal systemic effects in animal studies
  • Headache (theoretical, based on blood pressure effects)
  • Flushing or warmth at injection site
  • Mild inflammation at injection site
  • Dizziness if blood pressure drops too quickly
  • Allergic reactions to the peptide
  • Heart rhythm changes (requires monitoring)
  • Blood pressure, heart rate, cardiac function

Serious

  • Severe allergic reaction

BPC-157

Common

  • Injection site redness
  • Mild nausea
  • Dizziness

Uncommon

  • Headache
  • Fatigue
  • Hot/cold sensations

Serious

  • Allergic reaction

Research Status

Safety
& evidence

Apelin-13

Evidence Level

Moderate human trials (Phase 1-2)

FDA Status

Research compound

Safety Overview

Apelin-13 is a research compound with no human clinical trials or FDA approval. All safety data comes from animal studies and in vitro mechanistic work showing beneficial effects on vascular function and cardiac remodeling. However, animal models do not predict human safety, and the peptide's effects on immune regulation in humans remain untested. No dose-ranging studies, pharmacokinetics, or organ accumulation data exist in humans. The APJ receptor is expressed in multiple tissues including brain, raising concerns about off-target neurological effects at high doses.

Contraindications

  • xCurrently under investigation - not for human clinical use
  • xMay interact with blood pressure medications (in theory)
  • xShould not be used if allergic to peptides or component amino acids
  • xPregnant or breastfeeding individuals should avoid

BPC-157

Evidence Level

Strong preclinical (extensive animal studies)

FDA Status

Research compound

Safety Overview

BPC-157 is a gastric pentadecapeptide with strong preclinical evidence from extensive animal studies spanning over 25 years of research. Critical limitation: BPC-157 has NOT completed Phase 3 human clinical trials. No FDA approval exists. Safety data comes primarily from rat and mouse studies, with only limited Phase 1-2 human data. Animal studies show no toxicity at therapeutic doses, but human data is insufficient for regulatory approval. The peptide is unregulated, and no standardized manufacturing or quality control requirements exist for research compounds. Individual responses may vary significantly, and serious medical supervision is essential before use, particularly if you have gastrointestinal conditions, take medications, or have pre-existing medical conditions.

Contraindications

  • xPregnancy
  • xBreastfeeding
  • xActive cancer
  • xHistory of cancer

Decision Guide

Which is
right for you?

Choose Apelin-13 if...

  • Research into cardiovascular health and heart function
  • Understanding how the body naturally protects the heart
  • Exploring potential treatments for heart failure
  • Studying mechanisms of heart muscle strength

Choose BPC-157 if...

  • Injury recovery
  • Post-surgery healing
  • Chronic pain management
  • Gut health